<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04959955</url>
  </required_header>
  <id_info>
    <org_study_id>LM2016057</org_study_id>
    <nct_id>NCT04959955</nct_id>
  </id_info>
  <brief_title>Project to Improve the Diagnosis and Treatment Ability of Adult Severe Community Acquired Lower Respiratory Tract Infection</brief_title>
  <official_title>Project to Improve the Diagnosis and Treatment Ability of Adult Severe Community Acquired Lower Respiratory Tract Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Hospital of China Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Objective to understand the proportion of atypical pathogens in the pathogens of SCAP&#xD;
           and AECOPD in urban hospitals in China.&#xD;
&#xD;
        2. Objective to investigate the antimicrobial resistance of atypical pathogens in patients&#xD;
           with acute exacerbation of chronic obstructive pulmonary disease (COPD) and SCAP in&#xD;
           urban hospitals.&#xD;
&#xD;
        3. Objective to master the important clinical characteristics of patients with acute&#xD;
           exacerbation of SCAP and COPD caused by atypical pathogens and mixed infection in urban&#xD;
           hospitals in China, and to put forward the experience judgment index.&#xD;
&#xD;
        4. Objective to evaluate the advantages of various diagnostic methods for atypical&#xD;
           pathogens causing lower respiratory tract infection.&#xD;
&#xD;
        5. It is suggested that the current empirical treatment of SCAP and severe COPD in China&#xD;
           should be improved.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 8, 2015</start_date>
  <completion_date type="Actual">December 12, 2019</completion_date>
  <primary_completion_date type="Actual">July 10, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of atypical pathogens and mixed infections</measure>
    <time_frame>2year Incidence</time_frame>
    <description>Incidence of atypical pathogens and mixed infections</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>CAP</condition>
  <condition>COPD Exacerbation</condition>
  <arm_group>
    <arm_group_label>AECOPD group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>CAP group</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult hospitalized cases of SCAP and acute exacerbation of COPD were collected from 12&#xD;
        medical institutions in 10 cities in China within 2 years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  SCAP&#xD;
&#xD;
          -  AECOPD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating women.&#xD;
&#xD;
               -  Patients with bronchiectasis.&#xD;
&#xD;
                    -  Patients with active pulmonary tuberculosis.&#xD;
&#xD;
                         -  Aspiration pneumonia or obstructive pneumonia.&#xD;
&#xD;
                              -  Two weeks before the onset of hospital treatment history, this&#xD;
                                 infection can not be excluded from hospital acquired infection.&#xD;
&#xD;
                                   -  HIV positive patients (but HIV testing is not required).&#xD;
&#xD;
                                        -  Patients who are unable and / or unable to understand&#xD;
                                           and / or implement the investigation protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2021</study_first_posted>
  <last_update_submitted>July 4, 2021</last_update_submitted>
  <last_update_submitted_qc>July 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

